SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidias global settlement with United Therapeutics ends the pending litigation and keeps YUTREPIA available for PAH, while Liquidia will remove the PH-ILD indication and make substantial settlement payments. Traders broadly welcomed the resolution and expect possible short covering, but some remain concerned about the payment burden, lost PH-ILD opportunity, and whether the after-hours surge will hold.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of America is drawing attention after U.S. regulators imposed major penalties over anti-money-laundering and sanctions-compliance failures, with the charge adding uncertainty ahead of earnings. Traders are split between expecting further downside and viewing the fine as a manageable, already-known issue, with some looking to buy dips.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digitals proposed zero-interest convertible-note financing, alongside a planned exchange of existing notes for shares, has sparked concerns about dilution and selling pressure, contributing to a sharp decline. Some traders view the funding as favorable for its AI data-center expansion and are buying the dip, while others question the timing and shareholder impact.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians sustained share-price slide, despite reported delivery growth and R2 production-ramp progress, is driving debate ahead of earnings. Bears point to cash burn, profitability and execution concerns, while bulls see the R2 ramp and production expansion as reasons for optimism.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is caught in the AI-infrastructure selloff after OpenAIs reported revenue run rate came in below widely circulated expectations, prompting concerns about demand and the returns on heavy data-center investment. Traders are divided: bulls point to continued compute demand and the companys backlog, while bears focus on debt, financing costs, and dilution risk.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention amid a recent rise in trading and heavy call-option activity, as traders anticipate the REGAL Phase 3 AML trials 80th-event update and final results, with ASH also on the horizon. Some speculate that the move signals a data leak or acquisition talks, but neither is confirmed; others are skeptical and focused on the delayed milestone and lack of official news.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

CEO Ryan Cohens latest open-market share purchase is driving attention, with many traders viewing his repeated buying as a bullish signal and speculating about a short squeeze. Others question the muted price reaction and debate whether the warrant program could add dilution rather than fuel further gains.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Skydance Corp. - Ordinary Shares - Class B

Skydances distribution of long-dated warrants to eligible Class B shareholders is driving discussion, especially how separating the warrants affects the stock price and who qualifies amid brokerage delays and confusion. Traders disagree over whether the warrants add meaningful value or create dilution and selling pressure, with the companys heavy post-merger debt adding to bearish concerns.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

OUST is drawing attention amid volatile share-price weakness, with traders debating whether the pullback reflects broader market pressure and profit-taking or deeper concerns about valuation, dilution, and competition. Long-term bulls point to growing lidar deployments across drones, infrastructure, robotics, and autonomy as support for the Physical AI thesis, while skeptics question how quickly those use cases translate into profitable growth.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellias BLA for its HAE gene-editing therapy lonvo-z was accepted for FDA Priority Review, with a decision date set for March 2027, fueling discussion of a potential path to commercialization. Bulls view the milestone and clinical data as significant, while skeptics point to financing and cash-burn risks, heavy short interest, and the stocks weak reaction to positive news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hotter than expected

As expected

Cooler than expected

The September Consumer Price Index report lands Wednesday, October 14 at 8:30 AM ET, with economists forecasting headline inflation climbing to around 3.7% from August's 3.4% reading, just two weeks before the Fed's October 27-28 meeting. How will the September CPI print compare to consensus expectations? Vote and explain your reasoning in the comments.

How will the September CPI print compare to consensus expectations?

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

SKBBY Fundamentals